Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients

Primary care urgently needs treatments for coronavirus disease 2019 (COVID-19) patients because current options are limited, while these patients who do not require hospitalization encompass more than 90% of the people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: De Boeck, Ilke, Cauwenberghs, Eline, Spacova, Irina, Gehrmann, Thies, Eilers, Tom, Delanghe, Lize, Wittouck, Stijn, Bron, Peter A., Henkens, Tim, Gamgami, Imane, Simons, Alix, Claes, Ingmar, Mariën, Joachim, Ariën, Kevin K., Bakokimi, Diana, Loens, Katherine, Jacobs, Kevin, Ieven, Margareta, Bruijning-Verhagen, Patricia, Delputte, Peter, Coenen, Samuel, Verhoeven, Veronique, Lebeer, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604152/
https://www.ncbi.nlm.nih.gov/pubmed/36154666
http://dx.doi.org/10.1128/spectrum.01682-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604152/
https://www.ncbi.nlm.nih.gov/pubmed/36154666
http://dx.doi.org/10.1128/spectrum.01682-22

Ejemplares similares